An active metabolite of MPTP
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MPP+ Iodide

Item No. 16958

Technical Information
Formal Name
1-methyl-4-phenyl-pyridinium, monoiodide
CAS Number
36913-39-0
Synonyms
  • N-Methyl-4-Phenylpyridinium Iodide
Molecular Formula
C12H12N • I
Formula Weight
Purity
≥98%
A solid
Water: Soluble
SMILES
C[N+](C=C1)=CC=C1C2=CC=CC=C2.[I-]
InChi Code
InChI=1S/C12H12N.HI/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11;/h2-10H,1H3;1H/q+1;/p-1
InChi Key
RFDFRDXIIKROAI-UHFFFAOYSA-M
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Environmental Toxicology Resource Center

    Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.

    ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICES
    Product Description

    MPP+ is an active metabolite of MPTP, a neurotoxin used to cause selective destruction of dopaminergic neurons in animal models of parkinsonism.1,2,3,4 MPP+ induces neurotoxicity primarily by inhibiting complex I of the mitochondrial electron transport chain, resulting in ATP depletion and increased oxidative stress.5 The key features of different neurotoxic models of Parkinson’s disease, including the MPTP model, have been detailed.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Burns, R.S., Chiueh, C.C., Markey, S.P., et alA primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80(14), 4546-4550 (1983).

    2. Fritz, R.R., Abell, C.W., Patel, N.T., et alMetabolism of the neurotoxin in MPTP by human liver monoamine oxidase B. FEBS Lett. 186(2), 224-228 (1985).

    3. Javitch, J.A., D'Amato, R.J., Strittmatter, S.M., et alParkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82(7), 2173-2177 (1985).

    4. Goshima, Y., Misu, Y., Arai, N., et alNanomolar L-dopa facilitates release of dopamine via presynaptic β-adrenoceptors: Comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson’s disease. Jpn. J. Pharmacol. 55(1), 93-100 (1991).

    5. Tieu, K. A guide to neurotoxic animal models of Parkinson’s disease. CSH Perspect. Med. 1(1), (2011).